Massachusetts Neuroscience Consortium

At a Glance
  • Status: Active Consortium
  • Year Launched: 2012
  • Initiating Organization: Massachusetts Life Sciences Center
  • Initiator Type: Industry
  • Rare disease
  • Disease focus:
    Alzheimer's Disease, Multiple Sclerosis, Neuropathic Pain, Parkinson's Disease
  • Location: North America


The Massachusetts Neuroscience Consortium is designed to accelerate preclinical research available to the pharmaceutical industry, introduce academic researchers to the challenges of targeted research, and facilitate industry-academic partnerships. The consortium is comprised of pharmaceutical companies that recognize the value of leveraging the rich Massachusetts environment in the field of neuroscience. Through engagement with researchers working on central nervous system diseases, consortium members are seeking an opportunity to advance our collective understanding and treatment of such diseases.


The consortium’s purpose is to accelerate early-stage research available to the pharmaceutical industry. By providing funding to premier primary investigations in the state, the consortium aims to introduce academic researchers to the challenges of targeted research and facilitate industry-academic collaborations.

A number of factors make this consortium unique:

Consortium History

In July 2013, the center announced the first seven awards under the consortium, including three focused on Alzheimer’s, two focused on neuropathic pain, and one each focused on muscular sclerosis and Parkinson’s disease.


Each of the consortium members has contributed for a total available amount of project funding of $1,250,000. All funding decisions will be made by consortium members.


Other website

Sponsors & Partners

Biogen Idec

EMD Serono

Janssen Research and Development



Massachusetts Life Sciences Center

Last Updated: 04/08/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.